177 related articles for article (PubMed ID: 1626600)
41. DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices.
Bawani M; Tibrewala S; Copur S; Harris D; Gilman-Sachs A
Am J Gastroenterol; 1991 Feb; 86(2):191-5. PubMed ID: 1992633
[TBL] [Abstract][Full Text] [Related]
42. Comparison of deoxyribonucleic acid ploidy and nuclear expressed p62 c-myc oncogene in the prognosis of colorectal cancer.
Rowley S; Newbold KM; Gearty J; Keighley MR; Donovan IA; Neoptolemos JP
World J Surg; 1990; 14(4):545-50; discussion 551. PubMed ID: 2200214
[TBL] [Abstract][Full Text] [Related]
43. A 5- to 21-year follow-up and analysis of 250 patients with rectal adenocarcinoma.
Michelassi F; Block GE; Vannucci L; Montag A; Chappell R
Ann Surg; 1988 Sep; 208(3):379-89. PubMed ID: 3421761
[TBL] [Abstract][Full Text] [Related]
44. The role of flow cytometry in carcinoma of the colon and rectum.
Deans GT; Williamson K; Heatley M; Hamilton P; Arthurs K; Crockard A; Patterson CC; Rowlands BJ; Parks G; Spence RA
Surg Gynecol Obstet; 1993 Oct; 177(4):377-82. PubMed ID: 8211582
[TBL] [Abstract][Full Text] [Related]
45. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer.
Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y
Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755
[TBL] [Abstract][Full Text] [Related]
46. Preoperative carcinoembryonic antigen level as an independent prognostic factor in colorectal cancer: Taiwan experience.
Wang WS; Lin JK; Chiou TJ; Liu JH; Fan FS; Yen CC; Lin TC; Jiang JK; Yang SH; Wang HS; Chen PM
Jpn J Clin Oncol; 2000 Jan; 30(1):12-6. PubMed ID: 10770562
[TBL] [Abstract][Full Text] [Related]
47. Outcome of colorectal carcinoma in patients under 40 years of age.
Lin JT; Wang WS; Yen CC; Liu JH; Yang MH; Chao TC; Chen PM; Chiou TJ
J Gastroenterol Hepatol; 2005 Jun; 20(6):900-5. PubMed ID: 15946138
[TBL] [Abstract][Full Text] [Related]
48. Colorectal cancer in patients younger than 40 years of age.
Smith C; Butler JA
Dis Colon Rectum; 1989 Oct; 32(10):843-6. PubMed ID: 2791769
[TBL] [Abstract][Full Text] [Related]
49. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
Zarbo RJ; Nakhleh RE; Brown RD; Kubus JJ; Ma CK; Mackowiak P
Cancer; 1997 Jun; 79(11):2073-86. PubMed ID: 9179053
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of PDCD4 expression and association with microRNA-21 in each Dukes' stage of colorectal cancer patients.
Horiuchi A; Iinuma H; Akahane T; Shimada R; Watanabe T
Oncol Rep; 2012 May; 27(5):1384-92. PubMed ID: 22267128
[TBL] [Abstract][Full Text] [Related]
51. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study.
Ording AG; Horváth-Puhó E; Erichsen R; Long MD; Baron JA; Lash TL; Sørensen HT
Inflamm Bowel Dis; 2013; 19(4):800-5. PubMed ID: 23435402
[TBL] [Abstract][Full Text] [Related]
52. Studies in longstanding ulcerative colitis with special reference to malignant transformation of the colorectal mucosa.
Löfberg R
Acta Chir Scand Suppl; 1989; 552():1-45. PubMed ID: 2800882
[TBL] [Abstract][Full Text] [Related]
53. [Colorectal cancers associated with ulcero-hemorrhagic rectocolitis. Detection of and prognosis for postoperative patients].
Goudet P; Dozois RR; Viard H; Ilstrup D
Ann Chir; 1993; 47(9):826-31. PubMed ID: 8141547
[TBL] [Abstract][Full Text] [Related]
54. Morphological evaluation of colorectal carcinoma with grading staging and histological types.
Nabi U; Nagi AH; Riaz S; Sami W
J Pak Med Assoc; 2010 Dec; 60(12):998-1001. PubMed ID: 21381550
[TBL] [Abstract][Full Text] [Related]
55. Formal hepatic resection of colorectal liver metastases. Ploidy and prognosis.
Lind DS; Parker GA; Horsley JS; Kornstein MJ; Neifeld JP; Bear HD; Lawrence W
Ann Surg; 1992 Jun; 215(6):677-83; discussion 683-4. PubMed ID: 1632688
[TBL] [Abstract][Full Text] [Related]
56. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival.
Enker WE; Kimmel M; Cibas ES; Cranor ML; Melamed MR
J Natl Cancer Inst; 1991 May; 83(10):701-7. PubMed ID: 2023271
[TBL] [Abstract][Full Text] [Related]
57. DNA flow cytometry of endoscopically examined colorectal adenocarcinomas.
Giaretti W; Sciallero S; Bruno S; Geido E; Aste H; Di Vinci A; d'Amore ES
Pathol Res Pract; 1989 Nov; 185(5):589-93. PubMed ID: 2626368
[TBL] [Abstract][Full Text] [Related]
58. Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study.
Visscher DW; Zarbo RJ; Ma CK; Sakr WA; Crissman JD
Mod Pathol; 1990 Nov; 3(6):709-12. PubMed ID: 2263595
[TBL] [Abstract][Full Text] [Related]
59. Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients.
Diep CB; Thorstensen L; Meling GI; Skovlund E; Rognum TO; Lothe RA
J Clin Oncol; 2003 Mar; 21(5):820-9. PubMed ID: 12610180
[TBL] [Abstract][Full Text] [Related]
60. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.
Tribukait B; Hammarberg C; Rubio C
Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):89-95. PubMed ID: 6846020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
